The experimental results showed that the enhanced MUC1-CAR-T cells had significant anti-tumor effects on esophageal cancer cells, together with more sustained tumor killing and proliferative capacity compared with conventional MUC1-CAR-T cells. Here, MUC1 is linked to esophageal cancer.